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Abstract 
Background: Clostridium acetobutylicum represents a paradigm chassis for the industrial production of the biofuel 
biobutanol and a focus for metabolic engineering. We have previously developed procedures for the creation of in-
frame, marker-less deletion mutants in the pathogen Clostridium difficile based on the use of pyrE and codA genes as 
counter selection markers. In the current study we sought to test their suitability for use in C. acetobutylicum.
Results: Both systems readily allowed the isolation of in-frame deletions of the C. acetobutylicum ATCC 824 spo0A 
and the cac824I genes, leading to a sporulation minus phenotype and improved transformation, respectively. The 
pyrE-based system was additionally used to inactivate a putative glycogen synthase (CA_C2239, glgA) and the pSOL1 
amylase gene (CA_P0168, amyP), leading to lack of production of granulose and amylase, respectively. Their isolation 
provided the opportunity to make use of one of the key pyrE system advantages, the ability to rapidly complement 
mutations at appropriate gene dosages in the genome. In both cases, their phenotypes were restored in terms of 
production of granulose (glgA) and amylase (amyP). Genome re-sequencing of the ATCC 824 COSMIC consortium 
laboratory strain used revealed the presence of 177 SNVs and 49 Indels, including a 4916-bp deletion in the pSOL1 
megaplasmid. A total of 175 SNVs and 48 Indels were subsequently shown to be present in an 824 strain re-acquired 
(Nov 2011) from the ATCC and are, therefore, most likely errors in the published genome sequence, NC_003030 (chro-
mosome) and NC_001988 (pSOL1).
Conclusions: The codA or pyrE counter selection markers appear equally effective in isolating deletion mutants, but 
there is considerable merit in using a pyrE mutant as the host as, through the use of ACE (Allele-Coupled Exchange) 
vectors, mutants created (by whatever means) can be rapidly complemented concomitant with restoration of the 
pyrE allele. This avoids the phenotypic effects frequently observed with high copy number plasmids and dispenses 
with the need to add antibiotic to ensure plasmid retention. Our study also revealed a surprising number of errors 
in the ATCC 824 genome sequence, while at the same time emphasising the need to re-sequence commonly used 
laboratory strains.
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Background
Clostridium species are a diverse and large grouping of 
anaerobic, endospore-forming bacteria of importance 
both to medicine and industry [1]. To many, the term 
‘clostridia’ is synonymous with disease, a consequence 
of the exploits of such notorious human and animal 
pathogens as Clostridium botulinum, Clostridium tetani, 
Clostridium perfringens and Clostridium difficile [2]. The 
vast majority of the genus are, however, entirely benign 
and produce all manner of useful chemicals and fuels 
[3]. Of particular note are the saccharolytic species able 
to produce the biofuel n-butanol typified by Clostridium 
beijerinckii, Clostridium saccharolyticum, Clostridium 
saccharoperbutylacetonicum and Clostridium aceto-
butylicum [4]. All four species are associated with the 
Acetone-Butanol-Ethanol (ABE) commercial process [5], 
but it is the latter species that garners the most attention. 
Accordingly, attempts to develop tools for manipulating 
metabolism at the genetic level, both to understand and 
bring about improvements to the fermentative process, 
have tended to be skewed towards Clostridium acetobu-
tylicum [6].
Early strategies that sought to use recombination-
based methods to inactivate genes of C. acetobutylicum 
were handicapped by the lack of counter-selection mark-
ers for use in clostridia and, therefore, merely relied on 
the integration of the entire plasmid carrying an internal 
segment of the targeted gene [7–10]. As the plasmid car-
ried a marker gene coding for resistance to an antibiotic, 
the desired single crossover integrant could be selected 
on the basis of acquisition of resistance to that antibiotic 
through its inclusion in the agar medium. Such mutants 
were intrinsically unstable, a consequence of the pres-
ence of duplicated DNA regions via which homologous 
recombination led to excision of the integrated muta-
genic plasmid. Subsequently, researchers turned to the 
use of group II intron retargeting systems in which an 
intron-encoding segment of DNA could be deliberately 
inserted into the genomic target from where it could not 
excise [11–13]. The mutants generated were, therefore, 
extremely stable. Clones carrying the inserted intron-
encoding DNA could be detected by appropriate PCR 
screening, or in the case of the ClosTron, through selec-
tion for acquisition of resistance to erythromycin due to 
the incorporation of an inactivated ermB gene, or RAM 
(Retrotransposition Activated Marker), that became 
functional as a consequence of the successful insertion of 
the group II intron-encoding DNA into the genomic tar-
get [14–16].
The efficiency, reproducibility, speed and ease of use 
have led ClosTron technology to become the most widely 
used clostridial mutagen [17]. As with any insertional 
tool, however, its use is disadvantaged by the possible 
occurrence of polar effects on downstream genes which 
can complicate the subsequent analysis of mutant pheno-
types. As a consequence, marker-less, in-frame deletions 
generated by homologous recombination are preferred. 
Accordingly, in the past few years a number of groups 
have developed such methods through the success-
ful deployment of a range of counter-selection markers 
first exemplified in other microbial species. A number of 
the markers first reported could not be used in a stand-
ard wild-type host, but required a specific mutant back-
ground. These included the genes galK (galactokinase), 
pyrF (5-phosphate decarboxylase) and upp (uracil phos-
phor-ribosyltransferase), exemplified in C. perfringens 
[18], in Clostridium thermocellum [19] and in C. acetobu-
tylicum [20], respectively. Thereafter, a number of alter-
native counter selection markers have been described 
that can be used in a wild-type background, most nota-
bly use of the E. coli genes codA (cytosine deaminase) 
and mazF (mRNA interferase) in C. difficile [21] and C. 
acetobutylicum [22], respectively, and the exploitation of 
the Thermoanaerobacterium saccharolyticum tdk (thy-
midylate synthetase) and C. thermocellum hpt (hypox-
anthine phosphoribosyl transferase) genes to make 
knock-outs in C. thermocellum [23].
Of particular significance was the development of a 
method, now termed Allele-Coupled Exchange (ACE), 
which allows the rapid insertion of heterologous DNA, 
without inherent limits on size or complexity, into the 
genome [24]. Following integration of the plasmid by sin-
gle-crossover recombination, the system is designed such 
that during the desired second recombination event, 
a plasmid borne allele becomes ‘coupled’ to a genome 
located allele which leads to the creation of a new selecta-
ble allele, allowing the isolation of double-crossover cells. 
The use of highly asymmetric homology arms dictates 
the order of recombination events. A long homology 
arm directs the first recombination event (plasmid inte-
gration) and a much shorter homology arm directs the 
second recombination event (plasmid excision). Whilst 
a number of different genetic loci may be used to insert 
heterologous DNA via ACE, one exemplification of the 
method exploits the native pyrE gene, bringing about its 
inactivation by replacement of the wild-type allele with 
a mutant allele lacking approximately 300 bp from the 3′ 
end of the structural gene. The pyrE gene encodes oro-
tate phosphoribosyltransferase [E.C.2.4.2.10] which, in 
common with PyrF, is an enzyme involved in de novo 
pyrimidine biosynthesis. It may be used as a positive/
negative selection marker as it is essential in the absence 
of exogenous pyrimidines and renders 5-fluoroorotate 
(FOA) toxic to cells. It follows that a heterologous pyrE 
gene can be used as a counter-selection marker in such 
a strain, in an equivalent manner to pyrF [19], a facility 
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that was demonstrated in two different strains of C. dif-
ficile using a heterologous pyrE allele from Clostridium 
sporogenes [25]. Crucially, however, the design of the cre-
ated pyrE mutant strain is such that its pyrE allele can be 
rapidly (2 days) restored to wild-type using an appropri-
ate ACE correction vector allowing the specific in-frame 
deletion mutant to be characterised in a clean, wild-type 
background. Moreover, this facility provides the parallel 
opportunity to complement the mutant at an appropri-
ate gene dosage, through insertion of a wild-type copy of 
the gene, either under the control of its native promoter 
or the strong Pfdx promoter (derived from the ferredoxin 
gene of Clostridium sporogenes), concomitant with resto-
ration of the pyrE allele back to wild-type [25].
In the present study we have extended the significant 
advantages of the pyrE-based system to C. acetobutyli-
cum through appropriate deployment of ACE. At the 
same time, we took the opportunity to test the suitabil-
ity of using codA as a counter selection marker. During 
the course of this study, genome sequencing of the strains 
used revealed the presence of a significant number of 
SNVs (Single Nucleotide Variations) and Indels (Inser-
tions and Deletions) compared to that expected, empha-
sising the need for researchers to both establish the 
sequence of the strains in use in their laboratory and to 
appropriately curate their laboratory strains.
Results
Establishment of pyrE and codA Knock‑out Vectors for use 
in C. acetobutylicum
The use of pyrE as a counter selection marker in C. aceto-
butylicum required the construction of a knock-out (KO) 
vector suited to this clostridial species and the availability 
of an appropriate pyrE mutant host. The required pyrE 
(CA_C0027) mutant (CRG1545), lacking approximately 
300 bp from the 3′-end of the gene, has been previously 
made using ACE [24]. The existing pyrE-based, KO plas-
mid, pMTL-YN3 [25], used for making allelic exchange 
mutants in C. difficile 630 is based on a plasmid replicon 
(that of pCB102 [26]) shown to be replication defective 
in this particular clostridial strain [25]. Plasmid pMTL-
YN3 additionally carries a functional copy of the pyrE 
gene of C. sporogenes ATCC 15579 that had been tran-
scriptionally fused to a C. perfringens catP gene [27]. As 
the pIM13 replicon has previously proven most useful 
for allelic exchange vectors in C. acetobutylicum [24], 
the pCB102-derived [26] replicon of plasmid pMTL-
YN3 was replaced with that of pIM13 (Methods) and 
the plasmid obtained designated pMTL-ME3 (Fig.  1). 
To test that the C. sporogenes ATCC 15579 was func-
tional in C. acetobutylicum, CRG1545 was transformed 
either with plasmid pMTL-ME3 or a vector control lack-
ing pyrE, pMTL85141. Transformants were selected on 
CGM supplemented with 15 μg/ml thiamphenicol (Tm) 
and 20 μg/ml uracil and incubated for 24 h. Single colo-
nies were re-streaked onto the same medium followed 
by streaking onto CBM agar, without uracil. All the cells 
transformed with pMTL-ME3 showed growth similar to 
that of the C. acetobutylicum ATCC 824 wild-type but 
the cells transformed with the control vector pMTL85141 
and the plasmid-free CRG1545 grew very poorly on 
minimal medium (Additional file  4: Fig. S1). These data 
confirmed that the C. sporogenes ATCC 1557 pyrE gene 
was functional in C. acetobutylicum ATCC 824 and could 
most likely be used as a counter selection marker.
Similar to pMTL-YN3, the previously constructed 
codA-based KO vector pMTL-SC7315 used in C. difficile 
[21] is based on the replicon of pCB102 [26]. Accordingly, 
its replication region was also changed to that of pIM13 
(Methods) to give the plasmid pMTL-SC7515 (Fig.  1). 
Cytosine deaminase (EC 3.5.4.1) converts the innocu-
ous pyrimidine analogue 5-fluorocytosine (FC) into the 
highly toxic 5-fluorouracil (FU). FU toxicity occurs via 
uracil phosphoribosyltransferase (EC 2.4.2.9), followed 
by a series of steps that result in irreversible inhibition 
of thymidylate synthase, a key enzyme in nucleotide bio-
synthesis, and misincorporation of fluorinated nucleo-
tides into DNA and RNA [28, 29]. As the genome of C. 
acetobutylicum ATCC 824 [30] lacks any obvious codA 
gene but does carry a homologue of upp (CA_C2879), it 
would be predicted that the introduction of a functional 
codA gene should result in heightened sensitivity to FC. 
To test this assumption, the ATCC 824 wild-type was 
independently transformed with the codA-based plasmid 
pMTL-SC7515 and the vector pMTL85151 [31] and the 
sensitivity of the resultant transformants to FC assessed. 
The MIC of FC on CBM was reduced from 1  mg/ml 
(for the wild-type and pMTL85151 empty-vector con-
trol strain) to 100  µg/ml in those cells carrying pMTL-
SC7515 (data not shown). This confirmed that codA 
could most likely form the basis of a counter selection 
marker in C. acetobutylicum.
Establishment of ACE pyrE correction, complementation 
and overexpression vectors
A set of three ACE vectors were previously [24] estab-
lished for use in C. difficile knock-out mutants that pro-
vide the facility to either (1) simply ‘correct’ the pyrE 
allele of the host back to wild-type (a so-called pyrE 
‘correction’ vector), thereby allowing the establishment 
of a KO phenotype of a gene of interest in an otherwise 
wild-type background; (2) provide cloning sites down-
stream of the pyrE allele that allow a functional copy 
of the KO gene, together with its own promoter, to be 
inserted into the genome concomitant with correction of 
the pyrE allele, thereby allowing complementation at an 
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appropriate gene dosage and (3) provide cloning sites that 
are preceded by the strong Pfdx promoter that facilitate 
overexpression of the complementing gene. In C. difficile 
630, these vectors were designated pMTL-YN1, pMTL-
YN1C and pMTL-YN1X, respectively [23]. Accordingly, 
equivalent vectors were made for C. acetobutylicum, 
namely pMTL-ME6, pMTL-ME6C and pMTL-ME6X 
(Methods). As a quick check to establish that each vector 
was capable of correcting the pyrE allele, all three were 
independently transformed into CRG1545 and plated on 
CGM medium containing 20 µg/ml uracil and 15 µg/ml 
Tm, and selected colonies restreaked onto CBM lacking 
uracil and any antibiotic supplementation. In all cases, 
prototrophic colonies were isolated consistent with the 
correction of the pyrE allele.
Creation of mutants using codA as negative selection 
marker
To demonstrate the utility of codA as a counter selec-
tion marker in the generation of KO mutants, two genes 
were targeted, namely spo0A and the cac824I encoding 
the principal type II restriction system of C. acetobutyli-
cum. Appropriate KO cassettes, essentially comprising 
approximately 750  bp from upstream and downstream 
of the target gene, were assembled and cloned into 
pMTL-SC7515 as described in “Methods”. The two 
plasmids generated (pMTL-SC7515::spo0A and pMTL-
SC7515::cac824I) were transformed into the wild-type 
strain and the procedure described in “Methods” imple-
mented. This involved initially purifying single crossover 
integrants (through the selection of large, faster-growing 
transformants), transferring to un-supplemented CGM 
medium for 2–3 days to allow cells to undergo a second 
recombination event and then selecting FC-resistant cells 
on CBM agar plates supplemented with 100  µg/ml FC. 
All of those cells that retain the codA gene (either those 
still containing the autonomously replicating plasmid, 
or those in which the plasmid had integrated) are sensi-
tive to FC and are, therefore, unable to grow. In contrast, 
those cells in which the plasmid has excised, through a 
second recombination event, and has been lost due to 
segregational instability, are able to grow in the presence 
of FC. The loss of the KO vector was confirmed by replica 
plating on CGM with or without Tm supplementation.
In the case of the experiment that targeted spo0A, of 
the four random, FCR colonies screened by PCR using 
primers flanking the gene (Cac-spo0A-sF2 and Cac-
spo0A-sR2), one generated a DNA fragment of a size 
HpaI CatP FseI
SbfI
AscI
PmeI
ApaLI
HpaI
pMTL-ME2
5074bp
pMTL85141
2963bp
CatP FseI
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pMTL-SC7315
6000bp
CatP FseI
SbfI
AscI
PmeI
Ω(fdx)
NheI
EcoRI
ΩCD0164
pMTL-SC7515
5253bp
CatP FseI
SbfI
AscI
PmeI
Ω(fdx)
NheI
EcoRI
ΩCD0164
HpaI CatP FseI
HpaI
PmeI
PmeI
Fig. 1 Clostridial KO vector pMTL-ME3 and pMTL-SC7515. Plasmid components are: CatP, the catP gene of C. perfringens conferring thiamphenicol 
resistance; Csp-pyrE, the pyrE gene of C. sporogenes; ColE1 RNAII, the replication region of the E.coli plasmid ColE1; traJ, transfer function of plasmid 
RP4 oriT region; ΩCD0164, a transcriptional terminator isolated from downstream of the C. difficile strain 630 CD0164 gene; lacZα MCS, the lacZ’ 
gene encoding the alpha fragment of the E.coli β-galactosidase, containing a multiple cloning site, MCS, region derived from plasmid pMTL20; 
Ω(fdx), a transcriptional terminator of the ferredoxin gene of C. pasteurianum; repL is the replication protein of plasmid pIM13; codA, the cytosine 
deaminase gene of E. coli, and; the promoter in front of codA is the Pfac promoter of pMTL007
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(2114  bp) equivalent to the wild-type, the other three 
generated a 1679-bp DNA fragment consistent with the 
presence of the desired deletion (Fig.  2a). Nucleotide 
sequencing of the later fragments confirmed the pres-
ence of the expected in-frame deletion. Consistent with a 
sporulation defect, all three putative mutants were shown 
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1
2
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1
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b
Fig. 2 Isolation of in-frame deletion mutants of spo0A and cac824I. Schematic representations of the wild-type and mutant genomes in the 
targeted regions are shown above each electrophoretogram, together with the relative position of the two primers used and the extent of the 
Left Homology Arm (LHA) and Right Homology Arm (RHA) employed to mediate recombination. In both: MW, 2-log DNA marker (NEB) molecular 
weight marker; ‘W’, is a PCR with no DNA; ‘P’, is a PCR using the plasmid only, and; ‘WT’ is the wild-type strain CRG1268. a PCR screening of four FCR 
colonies (labelled lanes 1–4) using primers Cac-spo0A-sF2 (1) and Cac-spo0A-sR2 (2). Expected fragment sizes are 1679 bp in the deletion mutant 
and a 2114 bp fragment in the wild-type, respectively. Accordingly, labelled lane WT is wild-type, lanes 1, 3 (very weak band) and 4 are mutants. b 
PCR screening of seven FCR colonies (labelled lanes 1–7) using primers Cac-1501-sF2 (1) and Cac-1504-sR1 (2). Expected fragment sizes are 1611 bp 
in the deletion mutant and a 2319 bp fragment in the wild-type, respectively. Accordingly, labelled lanes 4–7 are wild-type, lane 2 is a mutant, and 
lanes 1 and 3 are a mixture of mutant and wild-type
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by microscopy to lack phase-bright spores and were una-
ble to form colonies after being subjected to heat treat-
ment at 80 °C for 10 min and plating on CGM agar and 
incubation for 24 h (data not shown).
In the experiment designed to KO cac824I, of the 
seven FCR colonies screened only one of them (clone 2) 
was confirmed as an in-frame deletion mutant, by gen-
eration of an appropriately sized fragment with the cor-
rect sequence (Fig.  2b). Four of the clones (clones 4–7) 
appeared to have reverted back to wild-type whereas 
1 and 3 appeared to be composed of a mixture of both 
wild-type and the in-frame deletion mutant. Insertional 
inactivation or deletion of cac824I by other groups has 
led to the observation that mutant cells can be trans-
formed with unmethylated DNA as efficiently as with 
methylated plasmid DNA [32, 33]. Consistent with 
this finding, 1.5 ×  104 transformants per µg DNA were 
obtained when Δcac824I was transformed with unmeth-
ylated plasmid compared to wild-type where no colonies 
were obtained.
In‑frame deletion of spo0A and its complementation using 
pyrE correction vectors
In parallel to the experiments with the codA-based vec-
tor pMTL-SC7515, the equivalent spo0A KO cassette was 
cloned into the pyrE-based KO vector pMTL-ME3, trans-
formed into the pyrE mutant C. acetobutylicum strain 
CRG1545 and subjected to the mutant isolation proce-
dure outlined in “Methods”. After two passages of nine 
independent TmR transformants on CGM supplemented 
with 15  µg/ml Tm, three of the visible larger colonies 
were single crossover integrants (two RH, one LH). Single 
crossover integrants were streaked onto CGM medium 
supplemented with 20  µg/ml uracil and incubated for 
2–3 days to allow cells to undergo a second recombina-
tion event. Bacterial cell suspensions in PBS were spread 
on CGM supplemented with 400 µg/ml FOA and 1 µg/ml 
uracil. The loss of the vector in those cells that grew was 
confirmed by demonstration that they could no longer 
grow when patch plated onto CGM medium contain-
ing 15 µg/ml Tm. A total of nine randomly selected TmS 
clones were screened using spo0A flanking PCR primers 
Cac-spo0A-sF2 and Cac-spo0A-sR2. A DNA fragment of 
a size (2114 bp) equivalent to the wild-type was obtained 
with one clone; five clones generated a 1679-bp frag-
ment consistent with the presence of the desired deletion 
while the remaining three generated both a wild-type and 
mutant DNA fragment (Fig.  3a). Nucleotide sequencing 
of the 1679-bp fragment of the five mutants confirmed 
the presence of the in-frame deletion.
Prior to measurements of their phenotype, the pyrE 
allele of all the mutants was corrected back to wild-type 
using the ACE correction vector pMTL-ME6 (Fig. 3b). 
Their sporulation minus phenotype was confirmed 
by the demonstration that none formed phase-bright 
spores after 2 to 5  days  growth in CBM supplemented 
with CaCO3 and that they could no longer form CFU 
when plated on CGM after an 80  °C heat shock for 
10  min (Fig.  4). In parallel to correction of the pyrE 
locus, complementation and overexpression experi-
ments were undertaken with one of the mutants, 
CRG3520. Accordingly, the spo0A gene together 
with its own promoter was cloned into pMTL-ME6C 
(yielding the pMTL-ME6C::spo0A) and into plasmid 
pMTL-ME6X downstream of the strong Pfdx promoter 
[14], to give plasmid pMTL-ME6X::spo0A. The two 
plasmids were transformed into CRG3520, selecting 
for TmR, and then restreaked onto CBM media lack-
ing uracil to select for clones in which the pyrE gene 
had been restored to wild-type. Confirmation that in 
both instances the spo0A gene had become integrated 
downstream of repaired pyrE gene was obtained using 
the flanking primers Cac0026-sF2 and Cac-hydA-sR2 
(Fig.  3c, d). Those mutant cells in which spo0A was 
inserted downstream of the corrected pyrE locus under 
the transcriptional control of its native promoter or the 
Pfdx promoter were completely restored to a wild-type 
phenotype, in terms of the presence of phase-bright 
spores in mature cultures and CFU after heat shock. An 
estimate of the number of spores produced by the vari-
ous cultures is shown in Fig. 4.
Although overexpression of spo0A using Pfdx promoter 
did not show any change in the sporulation frequency, 
a clear phenotypic change was observed as colonies of 
the overexpressed strain were visibly bigger compared 
to complemented and wild-type strains when grown on 
CBM medium after 24 h (Additional file 4: Fig. S2).
In‑frame deletion of the α‑amylase gene and its 
complementation using pyrE
To further test the system, and exemplify the utility of 
overexpressing complementing genes at the pyrE locus 
in mutant strains, it was desirable to use a mutant which 
had an easily visualised phenotype. An ideal candidate 
would be a secreted enzyme for which there is a simple 
plate-based assay that could measure zones of hydroly-
sis around a colony. Production of pectinase was initially 
considered to be an ideal candidate. To rapidly identify 
such a gene, intron insertion mutants were made using 
ClosTron technology [14] in CA_C0355, annotated 
as encoding polygalacturonase/pectinase, at two dis-
tinct insertion sites, 656a and 1167 s. No difference was 
observed in the size of the halo formation in the mutants 
compared to wild-type after staining of plates with iodine 
[34] (data not shown). This indicated either the targeted 
gene was not responsible for the observed pectinase 
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activity in the assay used or, more likely, more than one 
enzyme has such an activity.
As an alternative, the pSOL1 amyP gene (CA_P0168) 
was selected which is responsible for the production of 
an extracellular α-amylase when grown on medium con-
taining glucose as the sole carbon source. The expres-
sion of this gene could be easily assessed using CBM 
plates containing starch and stained with iodine. Loss of 
the pSOL1 megaplasmid, and by consequence amyP, is 
known to result in a loss of halo formation on medium 
containing starch [34]. This phenotype was confirmed 
by the initial generation of a ClosTron mutant, which 
showed a dramatic reduction in visible halo on starch 
iodine plates (data not shown). Accordingly, the C. aceto-
butylicum 824 pyrE mutant was transformed with vector 
pMTL-ME3::amyP (Methods), and the in-frame deletion 
procedure followed exactly as described for spo0A. Three 
FOAR colonies were screened for the putative mutation 
which exhibited a reduction in halo size on starch iodine 
plates of an equivalent size to that seen with the ClosTron 
mutant. PCR screening of these clones using primers 
flanking the amylase gene (Cac-amyP-sF2 and Cac-amyP-
sR2) resulted in the expected sized (2078 bp) DNA frag-
ment (Additional file 4: Fig. S3A). Nucleotide sequencing 
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Fig. 4 Sporulation frequency of the spo0A mutant and ACE-complemented derivatives. The various strains were cultivated in CBMS medium at 
37 °C and samples taken at 0, 24, 48, 72, 96 and 120 h, subjected to a heat shock (80 °C for 10 min) before plating at serial dilutions on CBM agar and 
incubated for 48 h. The number of colonies was counted and heat resistant Colony Forming Units per ml (CFU/ml) was calculated. Estimates were 
undertaken in triplicate. The detection limit of the assay is 50 CFU/ml, so no counts were recorded with the spo0A mutant control (not shown) or at 
0 h with any of the strains
(See figure on previous page.) 
Fig. 3 Screening of Spo0A mutants and ACE corrected/complemented/overexpressed clones. Key MW, 2-log DNA marker (NEB) molecular weight 
marker; ‘W’, is a PCR with no DNA; ‘P’, is a PCR using the plasmid only, and; ‘E’ is the pyrE minus parent strain CRG1545. On b, c the final arrange-
ment of the chromosomal region in the pyrE repaired strains is illustrated. Components are: dcd, deoxycytidine triphosphate deaminase; cac0026, 
hypothetical protein; pyrE, orotate phosphoribosyltranspherase; Pspo0A, promoter of the spo0A gene; Pfdx, promoter of the C. pasteurianum ferredoxin 
gene; spo0A, encodes the master regulator of sporulation, Spo0A; lacZ’, alpha-peptide of β-galactosidase gene containing multiple cloning sites; TT, 
transcriptional terminator found between hydA (hydrogenase) and pyrE. Arrows above and below the sequence labelled 1 and 2 show position of 
primers specific to each experiment. Lanes 1–9 (a), 1–2 (b) and 1–8 (c, d) are the screened DNA samples from randomly selected uracil prototrophic 
clones. a PCR screening of nine FOAR colonies using flanking primers Cac-spo0A-sF2 (1) and Cac-spo0A-sR2 (2). The expected PCR product for the 
mutant is 1679 bp, for the parent strain CRG1545 is 2114 bp. b PCR screening of the two uracil prototroph clones using flanking primers Cac0026-
sF2 (1) and Cac-hydA-sR2 (2). The expected PCR product for the pyrE mutant parent strain is 1936 bp and for the strain in which the pyrE allele 
has been restored to wild-type with pMTL-ME6 is 1989 bp. c PCR screening of eight uracil prototroph using flanking primers Cac0026-sF2 (1) and 
Cac-hydA-sR2 (2). The expected PCR product for the parent pyrE minus strain is 1936 bp and for the strain in which the pyrE allele has been restored 
to wild-type with pMTL-ME6C::spo0A is 3610 bp. d PCR screening of eight uracil prototroph using flanking primers Cac0026-sF2 (1) and Cac-hydA-
sR2 (2). The expected PCR product for the pyrE mutant parent strain is 1936 bp and for the strain in which the pyrE allele has been restored to wild-
type with pMTL-ME6X::spo0A is 3450 bp
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of this 2078-bp fragment confirmed the presence of the 
intended in-frame deletion.
A single mutant was selected and its pyrE allele was 
repaired, complemented and overexpressed using the 
ACE vectors pMTL-ME6, pMTL-ME6C::amyP and 
pMTL-ME6X::amyP, respectively, as described for the 
spo0A mutant. All the strains generated, together with 
the mutant and wild-type control, were grown overnight 
in 2x YTG broth. ODs were normalised and 20 µl of each 
culture was spotted on CBM agar plates containing 2 % 
starch and 0.5  % glucose and incubated for 48  h in an 
anaerobic cabinet. After 48 h, the plate was stained with 
iodine potassium iodide solution (Sigma 32922) for 1 min 
and photographed. The results (Fig. 5I) showed that there 
is no halo formation in the case of the mutant and size 
of halos is similar in the case of wild-type and comple-
mented strain while slightly bigger halo was evident in 
the case of the overexpression strain.
In‑frame deletion of the glgA gene  
and its complementation using pyrE
As a final test of the utility of the pyrE KO system, a 
mutation predicted to cause a defect in granulose accu-
mulation was targeted. Granulose is a starch-like storage 
compound that is accumulated in late exponential/sta-
tionary phase prior to sporulation and acts as a carbon 
and energy source for subsequent endospore formation. 
It is formed via the ADP-glucose pathway which requires 
ADP-glucose pyrophosphorylase (EC 2.7.7.27) and 
granulose synthase (EC 2.4.1.21) [35, 36]. The C. aceto-
butylicum ATCC 824 genome contains a cluster of genes 
involved in the glycogen formation (CA_C 2237- CA_C 
2239), that includes CA_C2239 (glgA) predicted to 
encode a glycogen synthase responsible for the forma-
tion of alpha-1,4-glucan chains from ADP-glucose [29]. 
Accordingly, a KO cassette directed against glgA was 
assembled and cloned into pMTL-ME3, and the result-
ant plasmid pMTL-ME3::glgA used to isolate an in-frame 
deletion mutant in CRG1545 using the standard protocol 
(Methods). In this instance, PCR screening of six ran-
dom FOAR clones using the flanking primers Cac-glg-sF2 
and Cac-glg-sR1 generated a DNA fragment from two 
of a size equivalent to that obtained with the wild-type 
(3112  bp), while two clones generated a DNA fragment 
of a size (1684 bp) consistent with that which would be 
obtained with a deletion mutant (Additional file  4: Fig. 
S4). PCR failed for the remaining two clones. Nucleotide 
sequencing of the 1684 bp fragment confirmed the pres-
ence of the intended in-frame deletion.
A single mutant was selected and its pyrE allele 
repaired using pMTL-ME6, pMTL-ME6C::glgA and 
pMTL-ME6X::glgA, the latter two plasmids correspond-
ing to pMTL-ME6C carrying the glgA gene together 
with its native promoter and pMTL-ME6X carrying 
Fig. 5 Phenotypes of the amylase and granulose mutants and complemented clones. I A 20 µl aliquot of a normalised overnight culture was 
spotted on CBM agar containing 2 % (w/v) starch, 0.5 % Glucose and plate stained with iodine potassium iodide solution after 48 h. A CRG4897, 
carrying a functional copy of amyP under the control of the Pfdx promoter inserted into the genome using the ACE vector pMTL-ME6X::amyP. B C. 
acetobutylicum ATCC 824 COSMIC strain wild-type. C CRG4896, carrying a functional copy of amyP and its own promoter inserted into the genome 
using the ACE vector pMTL-ME6C::amyP. D CRG4894, ΔamyP mutant. II All strains were grown on CBM agar plates with 5 % glucose to promote 
granulose formation and exposed to iodine vapours after 72 h. A CRG4898, ΔglgA mutant; B CRG4901 carrying a functional copy of glgA and its own 
promoter inserted into the genome using the ACE vector pMTL-ME6C::glgA; C CRG4902 carrying a functional copy of glgA under the control of the 
Pfdx promoter inserted into the genome using the ACE vector pMTL-ME6X::glgA. D C. acetobutylicum ATCC 824 COSMIC strain wild-type
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glgA under the control of the Pfdx promoter, respectively. 
The three clones generated were then tested for granu-
lose accumulation using CBM agar plates containing 5 % 
glucose and exposure to for 1 min to iodine vapour fol-
lowing growth for 72  h (Fig.  5II). These data confirmed 
that the glgA mutant no longer produced granulose and 
that its production was confirmed in both complemented 
strains. Any effect of placing the gene downstream of the 
strong Pfdx promoter was not discernible using this test.
High‑throughput sequencing of the pyrE and parent 
strains
Having generated the pyrE mutant CRG1545 to be used 
as the host for future mutational studies with pMTL-
ME3, it was important to establish that no major changes 
had occurred within the genome. The genome of the pyrE 
mutant strain (CRG1545) together with its parent strain 
(CRG1268) were, therefore, subjected to Illumina, single-
read sequencing and the data obtained mapped to the 
reference GenBank sequence NC_003030 (chromosome) 
and NC_001988 (pSOL1) using CLC Genomics Work-
bench. Surprisingly, a total of 177 SNVs and 49 Indels were 
shared by the parent and its pyrE mutant (Additional file 2: 
Table S2). Aside from the presence of the expected pyrE 
deletion, the pyrE deletion strain appeared to contain one 
additional SNV not present in the parent strain (Table 2). 
This equated to a G > A substitution in CA_C3553 at posi-
tion 3749347, which caused an Arg > Lys change at amino 
acid position 83 of an encoded LacI family transcriptional 
regulator. The presence of this change in the pyrE mutant 
(CRG1545), and not the progenitor CRG1268, was con-
firmed by the amplification of a region of DNA encom-
passing the SNV and subjecting it to Sanger sequencing.
For comparative purposes, ATCC 824 was re-acquired 
from the ATCC (November 2011) and designated as 
CRG3286, genome DNA prepared and subjected to Illu-
mina single-read re-sequencing. Of the 177 SNVs and 49 
Indels common to the ATCC 824 COSMIC consortium 
strain (CRG1268) and its pyrE mutant (CRG1545), 175 
and 48  (Additional file  2: Table S2), respectively, were 
also present in the newly acquired ATCC 824 genome 
(CRG3286). Of the two SNVs unique to CRG1268 and 
CRG1545, one occurred within CA_C1534 encoding an 
Iron ABC transporter ATP-binding protein and resulted 
in an amino acid substitution at position 303. The other 
resided just upstream of CA_C3087 (phosphoenolpyru-
vate-protein kinase). The remaining deletion comprised 
a 4916-nt region of the pSOL1 megaplasmid (position 
69715 to 74631, NC_001988)  (Table  3). This resulted in 
the deletion of four genes, namely manY/levF (mannose/
fructose-specific PTS comp. IIC), ptnd (mannose-spe-
cific PTS comp. IID), CA_P0069 (hypothetical protein) 
and CA_P0070 (HAD phosphatase superfamily protein) 
and partial deletion of ptna (mannose-specific PTS com-
ponent IIAB) and CA_P0071 (xylan degrading enzyme). 
The region deleted is flanked by a 10-bp sequence, 
TGACAACCAG at positions 69705–69714 and 74622–
74631, a repeat sequence that most likely mediated the 
4916-bp deletion. A closer examination of the mapping 
data for the ATCC 824 (COSMIC) Illumina reads against 
the pSOL1 sequence (NC_001988) revealed that the 
deleted region was present, but at a very low coverage (an 
average read occurrence of approximately 20 compared 
to 400 for the remainder of pSOL1).
As the presence of the large pSOL1 deletion in the 
pyrE strain was not ideal, we opted to remake the pyrE 
mutant in the re-acquired ATCC 824 strain. Accord-
ingly, the ACE vector pMTL-JH12 was used to remake 
the mutant as originally described [24]. The new mutant 
strain was designated CRG3899 and a paired-end library 
constructed from its genome and re-sequenced using 
Illumina technology. The new strain carried the same 
175 SNVs and 48 Indels common to the ATCC 824 re-
acquired parent strain, the COSMIC consortium strain 
and its pyrE mutant, but did not contain the ca. 5 kb dele-
tion present in pSOL1 or the CA_C3553 SNV found in 
the previous pyrE mutant (CRG1545). The re-sequencing 
analysis of the genome indicated that there were no addi-
tional SNVs or Indels compared to the parental wild-type 
strain.
Discussion
In the current study we have sought to extend two meth-
ods developed for making in-frame deletions in the 
important human pathogen C. difficile to the industrially 
important solvent producer, C. acetobutylicum. Both rely 
on the principle of pseudo-suicide [25], in which plas-
mids encoding an antibiotic resistance gene (catP, speci-
fying resistance to Tm) are employed that are replication 
defective and limit the growth rate of the population that 
harbours them in the presence of antibiotic (Tm). In con-
trast, cells in which the plasmid has integrated by single 
crossover recombination grow faster and produce larger 
colonies, because all of the progeny carry a copy of catP. 
Following the isolation of the pure single cross-over inte-
grants, cells are streaked onto media containing the coun-
ter selection agent (FOA or FC) to enable isolation of the 
double crossover mutant. The codA-based pMTLSC7515 
uses FC, and the pyrE-based pMTL-ME3 uses FOA. As 
the two procedures are essentially the same, they would 
be expected to be equally effective in their ability to iso-
late mutants. Nonetheless, it generally proved easier to 
isolated ‘pure’ single-crossover, integrant colonies using 
pMTL-SC7515 compared to pMTL-ME3, because the 
larger, faster growing colonies were more readily appar-
ent. Although both vectors employed are based on the 
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unstable replicon of plasmid pIM13 [31], the growth rate 
of C. acetobutylicum carrying pMTLSC7515 in the pres-
ence of antibiotic is slightly lower than that of C. acetobu-
tylicum carrying pMTL-ME3, and the culture achieves a 
lower final OD (Fig. 6). This is most likely a consequence 
of the larger size of pMTLSC7515 (5253 bp) compared to 
pMTL-ME3 (3561  bp), leading to a reduced replication 
efficiency.
For the isolation of double crossover mutants, the pure 
single crossover clones were plated onto media contain-
ing either FOA (pMTL-ME3) or FC (pMTL-SC7515). 
As the two plasmids are based on the same replicon 
and incorporate the same KO cassette for each targeted 
gene, they should be equally effective and the same num-
ber of mutants obtained. However, less screening was 
required to isolate mutants using pMTL-ME3 and FOA 
as fewer total colonies were generated suggesting that the 
rate of spontaneous mutants resistant to FOA was less 
than those that arose that were resistant to FC. Indeed, 
the majority of the FC colonies that arose still retained 
Tm resistance, even after several subcultures onto agar 
medium, suggesting that they retained an integrated 
plasmid and that spontaneous mutations elsewhere (i.e., 
in codA, upp) had led to acquisition of resistance to FC.
The primary aim of this study was the exemplification 
of the methods in an industrially relevant clostridia, so 
a number of the genes chosen for deletion had already 
been inactivated in the past. Thus, both systems read-
ily allowed the isolation of in-frame deletions of spo0A 
(master regulator of sporulation), previously mutated 
using ClosTron technology and shown to abolish sporu-
lation [13]. Similarly, an in-frame deletion of the gene 
CA_C1502 encoding the type II restriction endonuclease 
cac824I was created using pMTL-SC7515 and shown, as 
previously [32], to allow C. acetobutylicum to be trans-
formed with unmethylated plasmid DNA. The pyrE-
based system was additionally used to inactivate for the 
first time a putative glycogen synthase (CA_C2239, glgA) 
and the pSOL1 amylase gene (CA_P0168, amyP). In both 
cases the expected phenotype was obtained, in terms of 
lack of production of granulose and amylase, respectively. 
As these genes had not been previously inactivated, they 
provided the opportunity to make use of one of the key 
advantages of the pyrE system, the ability to rapidly com-
plement mutations at an appropriate gene dosage in the 
genome. In both cases, their glgA and amyP phenotypes 
were restored in terms of production of granulose and 
amylase.
In parallel, the opportunity was undertaken to assess 
the effect of overexpressing each complementing gene 
using the strong Pfdx promoter. There was a discern-
ible increase in the halo around the colony in which the 
genome integrated copy of amyP was under the tran-
scriptional control of Pfdx (Fig.  5I, A), in comparison to 
either the wild-type (Fig. 5I, B) or amyP combined with 
its native promoter (Fig. 5II, C). In contrast, no discerni-
ble difference could be seen in the simple plate assay used 
when the glgA gene was overexpressed. This is perhaps 
not surprising, as unlike amylase degradation of starch, 
there is more than one step in granulose formation, and 
granulose synthase may not represent the rate limiting 
step. During complementation of spo0A, the effect of 
overexpressing spo0A using Pfdx was also explored. No 
increase/decrease in the number of spores made com-
pared to when expression was from the native promoter 
was observed, although intriguingly, the colonies of the 
former were visibly larger (Fig.  5II). The reason for this 
change in colony morphology remains unknown.
The utility of pyrE clostridial mutants has been further 
demonstrated in the present study. Crucially, the mutants 
made are always characterised in an otherwise wild-type 
background as the pyrE mutant is always converted back 
to prototrophy, using ACE, prior to phenotypic charac-
terisation. This is in contrast, for instance, to the use of 
a pyrF mutant and corresponding pyrF-based counter 
selection marker in C. thermocellum, where the contin-
ued presence of the mutant pyrF allele causes a growth 
defect in the absence of exogenous uracil [19]. The C. ace-
tobutylicum pyrE deletion strain is unable to grow at all 
in CMBS media, but grows at a rate that is indistinguish-
able from the wild-type when the media is supplemented 
with exogenous uracil. The mutant produces essentially 
the same levels of solvents as the wild-type with possi-
bly a slight reduction in butanol levels (Additional file 4: 
Fig. S5). However, any reduction is of no consequence, 
Fig. 6 Growth curve comparison of pMTL-ME3 and pMTL-SC7515. 
Growth of C. acetobutylicum ATCC 824 in CBMS medium supple-
mented with 7.5 µg/ml of Tm transformed with vectors pMTL-ME3 
and pMTL-SC7515 with error bars representing the standard error of 
the mean (SEM) (n = 3)
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as the pyrE mutation is always repaired to prototrophy, 
using the ACE correction vector pMTL-ME6, with res-
toration of wild-type solvent yields (Additional file 4: Fig. 
S5). More importantly, mutants created in pyrE strains 
(by whatever means) can be rapidly complemented using 
ACE vectors by the introduction of a functional copy 
of the inactivated gene concomitant with restoration of 
the pyrE allele to wild-type. The extra effort involved in 
the deployment of ACE vectors compared to the use of 
automomous complementation vectors is minimal. They 
require the same amount of effort in terms of construc-
tion and transfer into the desired bacterial host. Trans-
formants carrying autonomous complementation vectors 
are purified by restreaking, whereas a transformant car-
rying an ACE complementation vector first needs to be 
restreaked onto a minimal plate lacking uracil, before 
purification by re-streaking of the selected prototrophic 
cell lines. The extra effort, therefore, equates to the time 
it takes for a uracil prototrophic colonies to develop, ca. 
2 days in the case of C. acetobutylicum. The efficiency of 
ACE is such that success is assured and, moreover, can-
not suffer from false positives as the nature of the pyrE 
deletion is such that reversion of the mutation is impossi-
ble. Although the effort required for ACE-mediated com-
plementation is minimal, the benefits are considerable. It 
avoids the phenotypic effects frequently observed with 
high copy number plasmids and dispenses with the need 
to add antibiotic to ensure the retention of the comple-
menting plasmid. Such antibiotic addition can affect phe-
notype and necessitate the inclusion in any phenotypic 
assessments of the mutant a vector only control.
The benefits of the presence of the pyrE locus are such, 
that there is a rational argument for using pyrE mutant 
hosts, and their cognate ACE correction vectors (e.g., 
pMTL-ME6, pMTL-ME6C and pMTL-ME6X), with any 
particular mutagen, including the ClosTron and any of 
the available negative selection markers [18–23]. More-
over, the pyrE allele represents an ideal position where 
other application-specific modules may be inserted, 
such as a sigma factor to allow deployment of a mariner 
transposon [37], hydrolases [38] and therapeutic genes 
in cancer delivery vehicles [39]. In view of these uses, 
it is important that one establishes that no detrimen-
tal SNVs or Indels have arisen in the genome during the 
construction of the pyrE host. In the case of the previ-
ously described C. difficile pyrE hosts, no such alterations 
were noted [25]. In this study a single G > A substitution 
(Arg  >  Lys) was evident in the pyrE mutant in a gene 
(CA_C3553) annotated as a LacI family transcriptional 
regulator. Whilst significance of this change is unknown, 
its existence is immaterial since the pyrE mutant was 
subsequently remade in the re-acquired ATCC 824 strain 
during which no extra SNVs or Indels arose. This strain 
(CRG3899) is, therefore, the ATCC 824 host of choice for 
mutational work in C. acetobutylicum.
The number of SNVs and Indels in the ATCC strain 
obtained from the University of Rostock, originally as 
the strain to be used by all consortium members of the 
ERANET SysMO project COSMIC, was surprising. 
However, upon resequencing it was apparent that the 
bulk of the changes were also present in the 824 deposit 
that currently resides at the ATCC. As a consequence it 
seems likely that these 175 SNVs and 48 Indels repre-
sent mistakes in the original genome sequence, the first 
clostridial genome to be determined and, therefore, at 
a time when technologies were less sophisticated [30]. 
Their authenticity seems reasonably certain given that 
CLC Bio Workbench called these differences in four 
independent genome sequence runs with the DNA of 
the current ATCC 824, the COSMIC consortium strain 
and the pyrE mutants of both these strains. Moreover, in 
every case, correction of the identified synonymous SNVs 
and Indels in the ATC 824 NC_003030 and NC_001988 
sequences that resided in coding regions resulted in 
ORFs that shared 100  % identity with the equivalent 
encoded proteins in the genome of C. acetobutylicum 
DSM 1731. Prior to this correction, some 90 of the ATC 
824 encoded proteins were not 100  % identical to their 
DSM 1731 counterparts and in a number of instances 
either initiated at a different point in the genome (three) 
or where substantially foreshortened (twelve). Follow-
ing correction of the latter changes, the C-terminal 
sequences of the encoding proteins were extended to 
give full-length sequences that were identical to the DSM 
1731 homologues. In a number of instances (seven) the 
changes resulted in the fusion of two formerly distinct 
genes in the ATCC genome (NC_003030) to give a single 
CDS identical to that present in DSM 1731 (NC_015687). 
The full list of changes is given in the Additional file  2: 
Table S2.
A number of sequences were, however, unique to the 
COSMIC consortium strain. These equated to 2 SNVs 
and 1 deletion. One of the SNVs occurs in the coding 
region of CA_C1534 (C to A, position 1678694) causing 
an Ala to Ser substitution in an ABC-type iron (III) trans-
port system (ATPase component) at position 303. The 
second SNV is a G to A substitution at position 3241095 
just upstream of CA_C3087 (phosphoenolpyruvate-
protein kinase). This particular substitution resides just 
upstream of the predicted -10 region of the promoter 
of CA_C3087 within the -35 region and could conceiv-
ably effect promoter activity. All of these SNVs were 
confirmed as present in the COSMIC strain, and not the 
re-sourced ATCC 824 strain, by Sanger sequencing of 
appropriately PCR amplified fragments. More significant 
was the 4916-nt deletion within the pSOL1 megaplasmid 
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(position 69715 to 74631, NC_001988) that encompassed 
a putative mannose PTS and related genes (Table 3). The 
presence of this deletion in the COSMIC consortium 
strain, but not the freshly sourced ATCC 824 strain, was 
confirmed by the PCR and subsequent sequencing of the 
amplified fragment using appropriate primers. A low 
number of reads across the deleted region were, however, 
present in the Illumina sequencing run suggesting that 
the strain represented a mixed population, in which the 
majority of the cells harboured a copy of the pSOL1 plas-
mid carrying the ca. 5 kb deletion. As those cells carry-
ing the deletion appeared to be in the majority, it was not 
unsurprising that the selected pyrE mutant was derived 
from this dominant subpopulation.
During the mapping of Illumina reads derived from the 
ATCC 824 COSMIC strain and its pyrE mutant, but not 
the re-acquired ATCC 824 strain, it was noted that read 
coverage over a ca. 53 kb region from position 2016385-
2069765 (in NC_003030) was some 20-fold higher (over 
4000 reads) than the rest of the genome (around 200 
reads) (Fig.  7). This region initiates with CA_C1867, 
annotated as a phage-related, Xre family transcription 
regulator, and ends with CA_C1957 which encodes a site 
specific recombinase. In between are 89 CDS encoding 
proteins with varying degrees of homology to proteins 
normally associated with bacteriophages. It suggests 
that during growth of the organism to prepare the DNA, 
the prophage most likely left the lysogenic state. Indeed, 
through the design of appropriate primers, it was possi-
ble to show, at least in some of the population from which 
the DNA was prepared, that the region had become cir-
cularised (Fig.  7). A similar increased coverage was not 
seen in the DNA that was prepared from the re-acquired 
ATCC 824.
It has previously been reported [40] that the DSM 
1731 genome contains 345 single nucleotide variations 
(SNVs) between its chromosome and that of ATCC 
824. Based on the revision to the ATCC 824 genome 
sequence proposed here, this would be expected to 
reduce that number to 170. However, mapping of the 
ATCC 824, paired-end Illumina reads generated as 
part of this study to the DSM 1731 reference sequence 
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Fig. 7 Evidence for excision of a prophage from the genome of C. acetobutylicum ATCC strain COSMIC. Screen shot of the mapped paired end reads 
of ATCC 824 COSMIC against the NC_003030 reference sequence over the region 2016385-2069765 encompassing a prophage. The indicated prim-
ers were used to show the region was present both in the chromosome (primers prophage-F1 and prophage-R1 and prophage-F2 and prophage-
R2) and as an excised circular form (primers prophage-R1 and prophage-F2). The coverage for the genome was on average just over 200, whereas 
for the prophage encoding region it was over 4000
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NC_015687 suggests that the actual number of SNVs is 
27, with a further two deletions and two insertions, one 
of which is the previously reported 1753 bp insertion at 
position 1278525 (see Additional file 3: Table S3 for the 
full list). In the case of the megaplasmid of ATCC 824, 
pSOL1  (Table  3), our re-sequence analysis identified a 
total of 4 SNVs and 1 deletion that were different to the 
published sequence (NC_001988). All four SNVs and the 
single deletion were present in the megaplasmid of DSM 
1731, pSMBa, suggesting that the original sequence of 
pSOL1 was incorrect. The deletion identified was a 4-bp 
deletion (ACTC) at position 191997 previously reported 
to distinguish pSMBa, and the megaplasmid in C. ace-
tobutylicum EA 2018, from pSOL1 [40]. All five changes 
were confirmed as correct by Sanger sequencing.
Having identified errors in both the published chromo-
somal (NC_003030) and pSOL1 (NC_001988) sequences, 
we compiled a new annotated reference sequence of both 
(Additional files 5, 6, respectively) that contained the cor-
rected chromosomal and pSOL1 sequences (Additional 
file  5, 6). These sequences were then used as references 
for the various Illumina sequence reads generated during 
this project. Using CRG_003030/CRG_001988, no SNVs 
or Indels were called during the analysis of the reads gen-
erated from the re-acquired ATCC 824 genome, and only 
those expected were called when sequence reads from 
the two pyrE mutants and the ATCC 824 COSMIC strain 
were used. Coincidentally, a new SNV was identified in 
the COSMIC strain in CA_C1989 which was not origi-
nally identified as it agreed with the incorrect NC_003030 
sequence at position 2102286. Thus, the substitution of a 
‘A’ for ‘C’ at CA_C1989 position 111 resulted in replace-
ment of a Gln with a Pro residue and an encoded Iron 
ABC transporter ATP-binding protein that is no longer 
identical to SMB_G2021 of DSM 1731. In addition, two 
SNVs were shown to be present in pSOL1 compared to 
pSMBa, resulting in amino acid substitutions in two ger-
mination proteins (Table 3). These were at position 82 of 
an amino acid permease, Grkb1 (Gly in pSMBa, Val in 
pSOL1) and at position 407 of a germination receptor, 
GerA (Ala in pSMB, Val in pSOL1).
Conclusions
The data presented here have demonstrated that in-
frame deletion, marker-less mutants can be isolated in 
the biobutanol organism, C. acetobutylicum, through 
a two-stage process of single crossover integration and 
the subsequent isolation of double crossover excision 
events using replication-defective plasmids and either 
the counter selection marker codA or pyrE. Either marker 
appears equally effective, but there is considerable merit 
in using a pyrE mutant as the host because, through the 
use of ACE vectors, mutants created in such strains (by 
whatever means) can be rapidly complemented. This 
avoids the phenotypic effects frequently observed with 
high copy number plasmids and dispenses with the need 
to add antibiotic to ensure the retention of the comple-
menting plasmid. Our study has also revealed a surpris-
ing number of errors in the the original genome sequence 
of ATCC 824, while at the same time emphasising the 
need to re-sequence commonly used laboratory strains.
Methods
Bacterial strains and routine culture conditions
Bacterial strains and plasmids used in this study are 
detailed in Table  1. Escherichia coli TOP10 (Invitrogen) 
was cultured aerobically (37  °C; shaking at 200  rpm) in 
Luria–Bertani LB medium supplemented with chloram-
phenicol (25 g/ml) where appropriate for plasmid cloning 
and storage, and TOP10 containing pAN2 plasmid [13] 
was used for in vivo methylation of plasmid DNA prior 
to transformation of C. acetobutylicum ATCC 824. C. 
acetobutylicum ATCC 824 was routinely grown anaero-
bically at 37  °C under an atmosphere of N2:H2:CO2 
(80:10:10, vol:vol:vol) in an anaerobic workstation (Don 
Whitley, Yorkshire, UK.) using media pre-reduced over-
night under the same conditions and grown in 2xYTG 
pH5.2 broth [41], Clostridium Basal Medium (CBM) 
[42] or on Clostridial Growth Medium (CGM) agar [43] 
supplemented with Tm (15  µg/ml) where appropriate. 
Uracil was supplemented at 20  µg/ml or 5-Fluoroorotic 
acid (FOA) (Europa Bioproducts Ltd) at 400 µg/ml in the 
media in the case of C. acetobutylicum ATCC 824 pyrE 
mutant. All reagents, unless noted, were purchased from 
Sigma-Aldrich (Tables 2, 3).
Transformation
Chemically competent cells of Escherichia coli TOP10 
were prepared using 0.1  M MgCl2 and 0.1  M CaCl2 as 
described in [43]. Ligation mixture or 10–20 µl or plas-
mids 1–2  µl were mixed with 50  µl of chemical com-
petent cells and incubated on ice for 10–15  min and 
transformed by heat shock method at 42 °C for 1 min in a 
PCR block, incubated for 1 min on ice followed by addi-
tion of 1 ml LB and incubating at 37  °C, 200 rpm shak-
ing for 30–60  min. Cells were centrifuged at full speed 
for 1 min and after re-suspending pellet in 200 µl of LB, 
100  µl of cells was plated onto LB agar supplemented 
with chloramphenicol (25  g/ml) and incubated over-
night at 37  °C. C. acetobutylicum ATCC 824 was trans-
formed by electroporation as described by [31]. After 
transformation, cells were mixed in 10 ml of 2xYTG pH 
5.2 and incubated at 37 °C for 2–3 h (supplemented with 
20 µg/ml uracil in the case of pyrE mutant) followed by 
centrifugation at 5000  rpm at room temperature and 
re-suspending the pellet in 300 µl of 2xYTG pH 5.2 and 
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Table 1 Strains and plasmids used in this study
Strain/plasmid Relevant features Reference/source
Strains
 E. coli Top10 F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 deoR recA1 araD139 Δ(ara-leu)7697 galU  
galK rpsL (StrR) endA1 nupG
Invitrogen
 C. acetobutylicum
ATCC 824 (COSMIC)
CRG1268 strain used in the ERANET (http://www.sysmo.net) SysMO project COSMIC. Originally 
from G. Bennet, RICE University, USA
H Bahl University  
of Rostock
 C. acetobutylicum
ATCC 824
CRG3286, resourced from the ATCC in November 2011 ATCC
 C. acetobutylicum
CRG1545
ΔpyrE mutant of CRG1268 made using the ACE vector pMTL-JH12 [24]
 C. acetobutylicum
CRG3899
ΔpyrE mutant of CRG3286 equivalent to CRG1268 This study
 C. acetobutylicum
CRG3520
Δspo0A of CRG1545 (ΔpyrE) made using pMTL-ME3::spo0A This study
 C. acetobutylicum
CRG4889
Δspo0A mutant of CRG1545 generated from CRG3520 by restoration of the pyrE allele to wild-
type using pMTL-ME6
This study
 C. acetobutylicum
CRG4890
CRG3520 (Δspo0A) carrying a functional copy of spo0A and its own promoter inserted into the 
genome using the ACE vector pMTL-ME6X::spo0A concomitant with restoration of the pyrE 
allele
This study
 C. acetobutylicum 
CRG4891
CRG3520 (Δspo0A) carrying a functional copy of spo0A under the control of the fdx promoter 
inserted into the genome using the ACE vector pMTL-ME6X::spo0A concomitant with restora-
tion of pyrE
This study
 C. acetobutylicum
CRG4893
In-frame deletion mutant of amyP (CaP0168) made using pMTL-ME3::amyP (pyrE vector with 
amyP KO cassette)
This study
 C. acetobutylicum
CRG4894
restoration of the pyrE allele to wild-type using pMTL-ME6 This study
 C. acetobutylicum
CRG4896
CRG4893 (ΔamyP) carrying a functional copy of amyP and its own promoter inserted into the 
genome using the ACE vector pMTL-ME6C::amyP concomitant with restoration of the pyrE 
allele
This study
 C. acetobutylicum
CRG4897
CRG4894 (ΔamyP) carrying a functional copy of amyP under the control of the fdx promoter 
inserted into the genome using the ACE vector pMTL-ME6X::amyP concomitant with restora-
tion of pyrE allele
This study
 C. acetobutylicum
CRG4883
In-frame deletion mutant of glgA (Cac2239) made using pMTL-ME3::glgA (pyrE vector with 
 glgA KO cassette)
This study
 C. acetobutylicum
CRG4898
ΔglgA mutant of CRG4883 generated from CRG1545 by restoration of the pyrE allele to wild-type 
using pMTL-ME6
This study
 C. acetobutylicum
CRG4901
CRG4883 (ΔglgA) carrying a functional copy of glgA and its own promoter inserted into the 
genome using the ACE vector pMTL-ME6C::glgA concomitant with restoration of the pyrE  
allele
This study
 C. acetobutylicum
CRG4902
CRG4883 (ΔglgA) carrying a functional copy of glgA under the control of the fdx promoter 
inserted into the genome using the ACE vector pMTL-ME6X::glgA concomitant with  
restoration of pyrE allele
This study
 C. acetobutylicum 
CRG2404
In-frame deletion mutant of spo0A gene made using pMTL-SC7515::spo0A This study
 C. acetobutylicum 
CRG2403
In-frame deletion mutant of the type II Restriction system Cac1502 made using pMTL-
SC7515::cac824I
This study
Plasmids
 pAN-2 E.coli vector (ф3T I methyltransferase gene, tet, p15a) CRG685 [13]
 pMTL85141 E.coli- Clostridium Shuttle vector (pIM13 catP ColEI) CRG1000 [31]
 pMTL-ME2 Clostridium KO vector (pCB102 catP ColE1 pyrE) CRG1668 [25]
 pMTL-ME3 Clostridium KO vector (pIM13 catP ColE1 pyrE) CRG1671This study
 pMTLSC7315 Clostridium KO vector (pCB102 catP ColE1 traJ codA) CRG1424 [21]
 pMTLSC7515 Clostridium KO vector (pIM13 catP ColE1 traJ codA) CRG1303 This study
 pMTL-ME6 C. acetobutylicum ACE correction vector (pIM13 catP ColE1 `pyrE) CRG1861 This study
 pMTL-ME6C C. acetobutylicum ACE complementation vector (pIM13 catP ColE1 pyrE lacZ’ MCS) CRG2483 [25]
 pMTL-ME6X C. acetobutylicum ACE expression vector (pIM13 catP ColE1 `pyrE Pfdx, lacZ’ MCS) CRG2482 [25]
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Table 1 continued
Strain/plasmid Relevant features Reference/source
 pMTL-ME3::spo0A pMTL-ME3 + spo0A KO cassette (pIM13 catP ColE1 pyrE) CRG1701 This study
 pMTL-ME3::amyP pMTL-ME3 + amyP KO cassette (pIM13 catP ColE1 pyrE) CRG3727 This study
 pMTL-ME3::glgA pMTL-ME3 + glgA KO cassette (pIM13 catP ColE1 pyrE) CRG4881 This study
 pMTL-SC7515::spo0A pMTLSC7515 + spo0A KO cassette (pIM13 catP ColE1 codA) CRG1672 This study
 pMTL-SC7515::cac824I pMTLSC7515 + cac824I KO cassette (pIM13 catP ColE1 codA) CRG2293 This study
 pMTL-ME6C::spo0A ACE complementation vector for spo0A CRG3739 This study
 pMTL-ME6X::spo0A ACE overexpression vector for spo0A CRG3738 This study
 pMTL-ME6C::amyP ACE complementation vector for amyP CRG3723 This study
 pMTL-ME6X::amyP ACE overexpression vector for amyP CRG3722 This study
 pMTL-ME6C::glgA ACE complementation vector for glgA CRG4900 This study
 pMTL-ME6X::glgA ACE overexpression vector for glgA CRG4880 This study
Table 2 Unique SNVs and  Indels, compared to  the current ATCC 824 strain, in  the laboratory ATCC 824 strain COSMIC 
and their pyrE mutants
a sequence identical to CA_C1989 in NC_003030 annotation at position 2102314 (G), but once the sequence is corrected to a ‘T’, the COSMIC ‘G’ at this position 
becomes a SNV
b CRG_003030.gbk is a corrected annotation of the ATTC 824 chromosomal genome sequence and is available as a Additional file 5
Strain NC_003030 Type Ref Allele Feature Change AA Change Function CRG_003030b
ATCC 824 COSMIC 1678711 SNV C A CA_C1534 907G > T Ala303Ser Iron ABC transporter  
ATP-binding protein
1678691
2102314a SNV G(T) G CA_C1989 332A > C Gln111Pro Iron (III) ABC transporter ATPase 2102286
3241117 SNV G T Miscellaneous – – Promoter region of CA_C3087 3241092
ATCC 824 COSMIC PyrE 3749367 SNV G A CA_C3553 248G > A Arg83Lys LacI family transcriptional 
regulator
3749536
Table 3 SNVs in the pSOL1 megaplasmid of C. acetobutylicum ATCC 824 COSMIC strain and re-acquired ATCC 824 strain
NC_001988 Type Ref Allele Feature Change AA Change Function/comment
ATCC 824 isolate re-acquired from the ATCC in November 2011
 18758 SNV G T CA_P0017 11C > A Ala4Glu GrkB germination protein, 4Glu also in SMB_P016 of DSM 1731
 54266 SNV A G CA_P0053 317T > C Leu106Pro Xylanase XYNB, now identical to SMB_P052 of DSM 1731
 56219 SNV A G CA_P0055 506A > G Asn169Ser Hypothetical protein, now identical to SMB_P054 of DSM 1731
 60555 SNV G T CA_P0059 754C > A His252Asn Alcohol dehydrogenase, now identical to SMB_P058 of DSM 1731
 191997 Del ACTC – Deletion – – Same deletion as in pSMBa of DSM1731
ATCC 824 COSMIC strain
 18758 SNV G T CA_P0017 11C > A Ala4Glu GrkB germination protein, 4Glu also in SMB_P016 of DSM 1731
 54266 SNV A G CA_P0053 317T > C Leu106Pro Xylanase XYNB, now identical to SMB_P052 of DSM 1731
 56219 SNV A G CA_P0055 506A > G Asn169Ser Hypothetical protein, now identical to SMB_P054 of DSM 1731
 60555 SNV G T CA_P0059 754C > A His252Asn Alcohol dehydrogenase, now identical to SMB_P058 of DSM 1731
 69715 Del 69715…74631 CA_P0066-71 del4916 bp – Unique to pSOL1, affects ptna, manY,ptnd, CA_P0069, CA_P0070, 
CA_p0071
 191997 Del ACTC – Deletion – – Same deletion as in pSMBa of DSM1731
DSM 1731 (map positions are to NC_015686)
 18524 SNV C A SMB_P016 245G > T Gly82Val GrkB, germination protein, Gly at position 82 instead of Val in CA_
P0017
 20626 SNV G A SMB_P019 220C > T Ala407Val GrkA, germination receptor, Ala at position 407 instead of Val in 
CA_P0020
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plating 100 µl onto CGM agar supplemented with 15 µg/
ml Tm and incubated at 37 °C in anaerobic conditions for 
24–48 h.
Cloning and PCR analysis
C. acetobutylicum ATCC 824 and C. sporogenes ATCC 
15579 genomic DNAs for use in cloning and PCR 
analysis were prepared using QIAGEN DNeasy Blood 
and Tissue Kit in accordance with the manufacturer’s 
instructions and recommended pretreatment for Gram-
positive bacteria using Lysozyme from chicken egg 
white (Cat L6876 Sigma-Aldrich) 20  ml/ml phosphate 
buffer saline (PBS) [25]. Screening PCRs were performed 
using DreamTaq™ green PCR master mix (Fisher Scien-
tific UK Ltd) and Failsafe™ PCR system (Epicentre) for 
downstream cloning in accordance with the manufac-
turer’s instructions. Primers were designed using web 
tool available at http://primer3.ut.ee and are listed in 
Additional file  1: Table S1. All the DNA manipulations 
including restriction digestion, de-phosphorylation of 5′ 
end and ligation were carried out according to standard 
procedures as described in [44]. DNA extraction and 
purification from agarose gel and PCR reaction mixtures 
were undertaken using QIAquick Gel Extraction and 
PCR Purification Kit (Qiagen Ltd UK), respectively, and 
used according to the manufacturer’s instructions.
Vector construction
The C. difficile knock-out (KO) vectors pMTL-YN3/
pMTL-ME2 (pyrE) and pMTL-SC7315 (codA) are based 
on the pCB102 plasmid replication region [21]. As 
plasmids that utilise the pIM13 replicon have proven 
highly effective as integration vectors in C. acetobu-
tylicum, the pCB102 replication regions of pMTL-ME2 
and pMTL-SC7315 were replaced with that of pIM13. 
Both pMTL-ME2 and pMTL-SC7315 correspond to the 
pMTL80000 modular format [31]. Their Gram-positive 
replicons are, therefore, flanked by AscI and FseI restric-
tion sites. Accordingly, their pCB102 replicons were 
excised by cleavage with AscI and FseI and replaced 
with 878 bp AscI/FseI fragment from the modular plas-
mid pMTL85141 [31] that encompassed the pIM13 rep-
lication region. The two new vectors were designated 
pMTL-ME3 (derived from pMTL-ME2) and pMTL-
SC7515 (derived from pMTL-SC7315). For chromosomal 
complementation and overexpression at the pyrE locus 
in mutants made using pMTL-ME3, plasmids pMTL-
ME6C and pMTL-ME6X were used, respectively [25]. 
For the ACE-mediated correction of the pyrE locus of 
CRG1545 back to wild-type, pMTL-ME6 a functional 
equivalent to pMTL-YN1 was made [25]. A fragment of 
1850 bp, encompassing regions of pyrE and hydA genes, 
was cloned by PCR using primers pyrE-LHAv1.0-F1 and 
hydA-RHAv1.0-R2 from C. acetobutylicum genomic 
DNA and was digested with HindIII and BglII and a 939-
bp fragment was purified from agarose gel and ligated 
into pMTL-JH14 [24] linearized with the same restric-
tion enzymes and confirmed by restriction analysis and 
Sanger sequencing.
KO plasmids
Allele exchange cassettes specific to target loci were 
either constructed by SOE PCR [45] or commercially 
synthesised. In every case the authenticity of each final 
plasmid was verified by restriction digestion and nucleo-
tide sequencing. Each cassette was composed of a left-
homology arm (LHA) and a right-homology arm (RHA), 
each 750 bp in size. The spo0A KO cassette was designed 
to make an in-frame deletion that removed 435  bp out 
of 846  bp and was composed of the C. acetobutylicum 
bases 2171926 to 2172675 (LHA) fused to bases 2173111 
to 2173860 (RHA) by SOR PCR. The flanking primers 
used added GTTTAAAC (a PmeI recognition sequence) 
at each extremity allowing the 1500-bp fragment to be 
blunt-end cloned into TA cloning vector pCR2.1 3929 bp 
and subsequently re-isolated as a BamHI/NotI frag-
ment and inserted between the BamHI and NotI sites of 
pMTL-ME3 and pMTL-SC7515 to yield plasmid pMTL-
ME3::spo0A and pMTLSC7515::spo0A, respectively. 
The KO cassette for CA_P0168 (amyP) was designed to 
delete 2277 bp of the 2283 bp long gene and comprised 
the C. acetobutylicum bases 180839 to 181588 (LHA) 
fused to bases 183866 to 184615 (RHA). It was synthe-
sised by Eurofine www.eurofinsgenomics.eu and was 
flanked by BamHI and NcoI restriction sites. Following 
cleavage by BamHI and NcoI it was inserted between 
the equivalent restriction sites of pMTL-ME3 to give 
pMTL-ME3::amyP. The KO cassette targeting the glgA 
gene was composed of bases 2332450 to 2333199 (LHA) 
of the C. acetobutylicum ATCC 824 genome fused bases 
2334628 to 2335377 (RHA) and was designed to remove 
1428 bp of the 1434 bp long gene. The PCR primers used 
were designed to position a NotI restriction recognition 
site adjacent to the LHA and a PmeI site at the extrem-
ity of the RHA. The cassette was isolated as a 1500-bp 
NotI/PmeI fragment and inserted between the NotI site 
and NheI (blunt-ended with T4 polymerase) sites of 
pMTL-ME3 to yield the KO plasmid pMTL-ME3::glgA. 
The in-frame deletion cassette for CA_C1502 (cac824I) 
consisted of the C. acetobutylicum bases 1645573 to 
1646322 (LHA) fused to 1647031 to 1647780 (RHA), 
which removes 708 bp from the 714 bp long gene. PmeI 
restriction sites were introduced as part of the SOE PCR 
flanking primers in the LHA and RHA which allowed 
the 1500-bp fragment to be isolated following diges-
tion with PmeI and inserted into the equivalent site of 
Page 18 of 20Ehsaan et al. Biotechnol Biofuels  (2016) 9:4 
plasmid pMTLSC7515 to resultant in the KO plasmid 
pMTL-SC7515::cac824I.
Complementation vectors
To complement those genes knocked out using the pyrE 
system, appropriate DNA fragments encompassing the 
structural gene and native promoter were cloned into 
the ACE vector pMTL-ME6C. The spo0A gene with its 
native promoter was amplified as a 1211-bp fragment 
using primers NotI-Cacspo0A-F1 and EcoRI-Cacspo0A-
R1 and following appropriate digestion cloned between 
the NotI and EcoRI sites of pMTL-ME6C to result in 
the plasmid pMTL-ME6C::spo0A. Similarly, the C. ace-
tobutylicum ATCC 824 amyP gene (CA_P0168) was 
PCR amplified using primers Pca_P-0168-F1 and Ca_P-
0168-R1 and the 2505-bp PCR product cleaved with 
NotI and BamHI and inserted between the equivalent 
sites of pMTL-ME6C. The plasmid obtained was des-
ignated pMTL-ME6C::amyP. To bring about overex-
pression of the complementing gene, promoter-less 
copies were cloned into pMTL-ME6X downstream 
of the strong Pfdx promoter. The spo0A gene was PCR 
amplified from genomic DNA using primers NdeI-Cac-
spo0A-F1 and EcoRI-Cacspo0A-R1. The PCR product 
obtained (859  bp) was digested with NdeI and EcoRI 
and ligated downstream of the Pfdx promoter in pMTL-
ME6X linearized with the same restriction enzymes, to 
make pMTL-ME6X::spo0A.
To construct an over-expression vector for amyP, the 
gene was PCR amplified from genomic DNA without 
its promoter using Ca_P-0168-F2 and Ca_P-0168-R1. 
The start codon of the gene was changed from TTG to 
ATG using AseI in the forward primer which was com-
patible with NdeI. The 2300-bp PCR product obtained 
was digested with AseI and BamHI and cloned in 
pMTL-ME6X linearized with NdeI and BamHI to make 
pMTL-ME6X::amyP. However, cells transformed with 
this plasmid were negative for amylase activity by the 
starch-iodine plate test. To remedy this lack of expres-
sion, the ATG was changed back to the original TTG 
start by making a quick change in the vector using oli-
gonucleotides Qfdx-0168-F1 and Qfdx-0168-R1, while 
at the same time reducing the spacer region between 
the start codon and ribosome binding site by one base 
pair.
Allelic exchange procedure
The procedure used for the isolation of the in-frame 
deletion mutants in C. acetobutylicum using either 
pMTL-ME3 or pMTL-SC7515 is essentially the same 
and based on the procedures described by Ng el et  al. 
[25] and Cartman et al. [21], respectively. Derivatives of 
the two vectors carrying the required KO cassette were 
electroporated into either the wild-type (pMTL-SC7515) 
or the pyrE mutant strain (pMTL-ME3) and plated on 
CGM supplemented with 15  µg/ml Tm and incubated 
for 24–48  h. The largest representative colonies were 
selected and passaged twice by re-streaking onto the 
same agar media, at each stage choosing larger repre-
sentative colonies. The cells of selected colonies were 
then screened by PCR to ascertain whether the isolated 
clonal population was a pure single crossover integrant, 
using appropriate pairs of primers. These comprised a 
forward primer complementary to the chromosome and 
a reverse primer specific to a plasmid encoded region. 
The presence of a PCR product indicated that the clones 
were single crossover integrants, and the size of PCR 
product indicated at which homology arm (LHA or 
RHA) recombination had happened. It was important to 
establish purity, as the presence of cells in which integra-
tion had not occurred would contribute to a high back-
ground level of colonies when subsequently plated on 
the counter selection agents, FOA and FC.
Pure single, crossover clones were plated onto  CGM 
supplemented with 20 µg/ml uracil or un-supplemented 
CGM medium and incubated for 2–3 days to allow cells 
to undergo a second recombination event, resuspended 
in PBS and appropriate dilutions spread on CGM agar 
plates supplemented with either FOA (400  µg/ml) and 
uracil (1 µg/ml) or CBM supplemented with FC (100 µg/
ml) for pMTL-ME3 and pMTL-SC7515, respectively, and 
incubated for 48 h. Only cells that have, respectively, lost 
pyrE or codA through excision of the plasmid and its sub-
sequent loss from the cell may grow. The loss of the KO 
vector was confirmed by patch plating on CGM with or 
without Tm supplementation. As the excision event may 
be mediated by either of the two homology arms (LHA 
or RHA), the cell line that arises can be either mutant or 
wild-type. Where there is no homology arm preference, 
then the ratio of mutant to wild-type should be 50:50. 
However, this is rarely the case. Moreover, if one homol-
ogy arm is favoured at the single crossover integration 
stage, then it will be favoured at the double crossover 
stage and as a consequence the proportion of wild-type 
derivatives will be higher.
Screening of FCR and FOAR clones by PCR was under-
taken using primer pairs that flanked the desired dele-
tion point and were complementary to chromosomally 
located sequence that resided external to the homol-
ogy arms used. For example, Cac-spo0A-sF2 and Cac-
spo0A-sR2 in the case of spo0A; Cac-1501-sF2 and 
Cac-1504-sR1 in the case of cac824I; Cac-amyP-sF2 and 
Cac-amyP-sR2 in the case of amyP and; Cac-glg-sF2 and 
Cac-glg-sR1 in the case of glgA. The PCR products gen-
erated were subjected to Sanger sequencing to confirm 
their authenticity.
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Correction of pyrE using ACE
The ACE procedure adopted is essentially as described 
before [24]. Plasmids pMTL-ME6 and the derivatives of 
pMTL-ME6C and pMTL-ME6X prepared from E. coli 
pAN2 were transformed into the appropriate C. aceto-
butylicum mutant and TmR transformants selected onto 
CGM agar supplemented with 15 µg/ml Tm and 20 µg/
ml uracil. Selected large colonies (single crossover inte-
grants) were then streaked onto CBM lacking uracil 
supplementation to select plasmid excised derivatives 
(double crossover cells) in which the pyrE allele had been 
restored to wild-type and the cells had become prototro-
phic. PCR primers Cac0026-sF2 and Cac-hydA-sR2 were 
used to screen for authentic clones and the amplified 
fragment subject to nucleotide sequencing.
High‑throughput sequencing
Phenol chloroform method was used to isolate genomic 
DNA from strains CRG1268 (COSMIC wild-type strain), 
CRG1545 (COSMIC strain pyrE mutant), CRG3286 (re-
acquired ATCC 824) and CRG3899 (re-acquired ATCC 
824 pyrE mutant). CRG1268, CRG1545 and CRG3286 were 
sequenced by Illumina hiseq (GATC, Germany) with read 
lengths of 101, 51 and 51, respectively. For the sequenc-
ing of CRG3899 paired-end libraries were prepared and 
sequenced (251 bp reads) using an Illumina MiSeq bench-
top sequencer (Deepseq, University of Nottingham). Prepa-
ration of paired-end libraries as well as sequencing was 
performed as described by the manufacturers. Sequence 
reads were mapped to the reference sequences NC_003030 
(chromosome) and NC_001988 (pSOL1) using CLC 
Genomics Workbench. We used a frequency of 90  % as 
a cut-off for SNV calling. Selected SNVs and InDels were 
confirmed by amplifying a few hundred base pairs up- and 
downstream of the area of interest and the amplicon was 
Sanger sequenced (Source BioScience, UK).
Sporulation assay
Spore stocks of test strains were heat treated at 80  °C 
for 10  min before plating on pre-reduced CBM agar 
and incubation for 24  h. Triplicate pre-cultures were 
prepared by resuspending a loop-full of colonies from 
each strain into three universal tubes containing 10  ml 
CBMS medium (CBM + 0.5 % w/v CaCO3, 5 % w/v glu-
cose) and incubated overnight. The following day, tripli-
cate sporulation assay cultures (30 ml CBMS medium in 
50 ml-Falcon tubes) were inoculated to an initial OD600 
nm 0.048-0.0065 from the pre-cultures. Aliquots of 
200 µl were removed at 0, 24, 48, 72, 96, and 120 h. Sam-
ples were heated at 80 °C for 10 min in a water bath and 
dilutions (10−1–10−6) were prepared in 96 well microti-
tre plate. From each strain, 20  µl volumes were spotted 
onto CBM agar and incubated for 48  h. The number of 
colonies was counted and heat_resistant Colony Forming 
Units per ml (CFU/ml) was calculated.
Detection of granulose
Granulose accumulation was tested by growing the C. 
acetobutylicum ATCC 824 strains on agar-solidified 
CBM containing 5 % glucose to promote granulose accu-
mulation. After incubation for 72 h, plates were exposed 
to iodine vapour, staining granulose-containing colonies 
dark brown.
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